Skip to content
Sukalyan Research Group

what we study

Research

The group combines wet-lab work, animal models and computation: screening medicinal plants, measuring toxicity in rodent models, formulating and testing dosage forms, and using molecular docking to study how drugs and natural compounds interact with their targets.

research area 01

Phytopharmacology and herbal drug validation

Testing Bangladeshi medicinal plants for the activities traditional medicine attributes to them, and identifying the compounds responsible.

Bangladesh has a rich tradition of plant-based medicine, but many remedies have never been tested under controlled conditions. The group extracts and screens indigenous species for antioxidant, hepatoprotective, antidiabetic, analgesic, anti-inflammatory, cytotoxic and antimicrobial activity, then uses phytochemical profiling to connect each activity with specific constituents.

Species studied include Justicia gendarussa, Bridelia tomentosa, Citrus medica, Syzygium cymosum, Spondias pinnata, Marsdenia tenacissima, Catharanthus roseus, Basella alba and Eucalyptus camaldulensis.

Highlights

  • Hepatoprotective and antioxidant activity of plant extracts in rat models
  • GC-MS and FTIR guided phytochemical profiling
  • Ethnomedicinal surveys of folk and tribal medicinal practitioners

Techniques

  • Solvent extraction
  • DPPH and nitric oxide scavenging
  • Brine shrimp lethality
  • In vivo rodent models

research area 02

Toxicology and safety assessment

Measuring how pesticides, heavy metals and contaminants damage the body, and whether plant compounds can protect against that damage.

A long-running line of work examines carbofuran, a widely used carbamate pesticide, and the hematological and hepatic damage it causes in animal models. Plant extracts rich in phenolic acids and flavonoids are then tested for their ability to reduce that oxidative injury. This work has appeared in Chemical Research in Toxicology, Toxicology Reports and the South African Journal of Botany.

The group also assesses everyday exposure risks in Bangladesh, including heavy metals in cosmetics, hexavalent chromium in broiler meat and Salmonella in fish, as well as the chronic toxicity of combination drugs sold on the local market.

Highlights

  • Carbofuran-induced hepatic and hematological toxicity
  • Human health risk from heavy metals in cosmetics
  • Toxicity profiling of herbal extracts

Techniques

  • Hematology and serum biochemistry
  • Histopathology
  • Oxidative stress markers
  • Health risk assessment

research area 03

Computational pharmacology and molecular docking

Using docking, ADMET prediction and pharmacoinformatics to understand how drugs and natural compounds interact with their targets.

Computational methods let the group ask questions that would be slow or costly to answer at the bench. Recent studies mapped where benzodiazepines bind on the GABAA receptor, compared how montelukast, zafirlukast and gemilukast bind CysLTR1, P2Y12 and PPAR-gamma, and predicted the chronic toxicity of antihypertensive combinations such as olmesartan medoxomil with hydrochlorothiazide.

The same tools screen natural products for antiviral leads, including compounds from Nigella sativa and breadfruit against SARS-CoV-2 targets, and support immunoinformatics work such as epitope-based vaccine design against dengue virus.

Highlights

  • Site-specific binding of benzodiazepines at the GABAA receptor
  • In silico toxicity of marketed combination drugs
  • Natural product leads against SARS-CoV-2

Techniques

  • AutoDock
  • Molecular docking
  • ADMET profiling
  • In silico toxicity prediction
  • Immunoinformatics

research area 04

Drug delivery and formulation science

Designing tablets, pellets and hydrogels that release medicines at the right rate and in the right place.

Much of the group's formulation work focuses on controlled release: HPMC-based matrix tablets for drugs such as gliclazide, metronidazole, ciprofloxacin, indapamide and trimetazidine, ranitidine pellets made by extrusion spheronization, and solid dispersions that help poorly soluble drugs such as carbamazepine and glimepiride dissolve faster.

Collaborative work has extended this to polymer systems, including a pH-sensitive gelatin and polyvinyl alcohol hydrogel for methotrexate delivery, and to the 2025 book Polymer-Based Drug Delivery: Bridging Science and Therapeutics (IGI Global).

Highlights

  • Sustained-release HPMC matrix tablets
  • Mouth-dissolving tablets from solid dispersions
  • pH-sensitive hydrogels for methotrexate

Techniques

  • Matrix tablet fabrication
  • Extrusion spheronization
  • Solid dispersion
  • Hydrogel preparation
  • Release kinetics

research area 05

Analytical method development and validation

Building and validating the HPLC and UV methods that quality control laboratories rely on.

Reliable medicines depend on reliable measurement. The group develops and validates RP-HPLC and UV-spectrophotometric methods for active ingredients in bulk and dosage forms, including sitagliptin, saxagliptin, daclatasvir, tiemonium methylsulfate, ranitidine and calcium orotate.

Related studies compare the potency, dissolution and stability of commercial brands marketed in Bangladesh, an important check on product quality in a fast-growing pharmaceutical market.

Highlights

  • RP-HPLC methods for antidiabetic and antiviral drugs
  • Brand comparison of potency and dissolution
  • Stability of topical formulations

Techniques

  • RP-HPLC
  • UV spectrophotometry
  • Dissolution testing
  • Method validation

research area 06

Cancer therapeutics

Exploring sonodynamic and photodynamic therapy and plant-derived anticancer agents.

During his postdoctoral fellowship at the University of Fukui, Prof. Kundu worked with Dr. Norio Miyoshi on combining sonodynamic and photodynamic therapy, using nanoparticles of regulated size to improve tumour selectivity. The collaboration produced a joint paper in Nanoscience and Nanoengineering and a PACIFICHEM 2015 symposium book on spectroscopic tools for cancer diagnosis and treatment.

In Bangladesh the group reviews and tests medicinal plants with anticancer potential and has examined patterns of cancer and its treatment in hospitals in Dhaka.

Highlights

  • Combined sonodynamic and photodynamic therapy
  • Medicinal plants with anticancer effect
  • Cancer treatment patterns in Dhaka hospitals

Techniques

  • Cytotoxicity screening
  • Nanoparticle-assisted therapy
  • Spectroscopic methods

research area 07

Clinical and public health research

Working with physician researchers on diabetes care, pain medicine, maternal health and medicine use in Bangladesh.

Many of the group's PhD researchers are practising clinicians, which keeps the lab close to patients. Joint studies have looked at cost-effective oral hypoglycaemic agents for low-income patients with type 2 diabetes, pharmacist-led diabetes self-management, risk factors for knee osteoarthritis, thalassemia trait in pregnancy, vitamin D status in intensive care and periodontal disease in Dhaka.

The group also studies how people use medicines, including perceptions of complementary and alternative medicine among university students, and shares medicine-safety messages with the public through television and online health education.

Highlights

  • Affordable diabetes treatment for low-income patients
  • Pain medicine and musculoskeletal studies
  • Medicine use and perception surveys

Techniques

  • Clinical study design
  • Patient surveys
  • Epidemiological analysis

how we work

Methods and expertise

The techniques used across the group's projects, grouped by discipline.

  • Computational and in silico

    • AutoDock
    • Molecular docking
    • ADMET profiling
    • In silico toxicity prediction
    • In silico drug design
  • Analytical techniques

    • HPLC
    • RP-HPLC
    • UV spectrophotometry
    • Dissolution testing
    • Method validation
  • Formulation science

    • Matrix tablet fabrication
    • Extrusion spheronization
    • Hydrogel preparation
    • Sustained-release systems
  • Biological assays

    • In vivo animal models
    • DPPH and nitric oxide scavenging
    • Brine shrimp lethality
    • Antimicrobial screening
  • Histopathology

    • Immunohistochemistry
    • Tissue processing
    • Mucosal pathology
    • Lymphatic vessel characterization
  • See these methods at work in the group's journal articles, books and book chapters.

    Browse publications

where our members went next

Alumni Destinations

Academic and research institutions where our lab members have advanced their careers.

  • Ames National Laboratory logo
  • Beacon Pharmaceuticals logo
  • University of Fukui logo
  • GSK logo
  • Incepta Pharmaceuticals logo
  • Jadavpur University logo
  • King's College London logo
  • Massachusetts Institute of Technology logo
  • Renata PLC logo
  • Square Pharmaceuticals logo
  • Broad Institute logo
  • Harvard University logo
  • The Ohio State University logo
  • Pfizer logo
  • Yale University logo
  • The University of Newcastle logo
  • University of Toronto logo
  • UCL logo
  • Novartis logo